Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

An earlier version of this story reported that the virus had been detected since then.) The number of bird flu ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...

To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...